Copertina

Highlights of 2024: unleashing the power of NK cells—cancer's worst nightmare

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Capucine Bourel, Fernando Souza‐Fonseca‐Guimaraes, Sylvie Lesage
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Immunology & Cell Biology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Highlight of 2023: From fundamental studies to clinical trials, the importance of NK cells against cancer
di: Capucine Bourel, et al.
Pubblicazione: (2024)

Highlights of 2024: Cytokines and ligands modulating NK cell effector functions
di: Aneena Mary Shajan, et al.
Pubblicazione: (2025)

Highlight of 2023: Thymic B cells—important players in the establishment of T‐cell tolerance
di: Félix Lombard‐Vadnais, et al.
Pubblicazione: (2024)

CAR‐NK cell‐based therapies: translational and regulatory breakthroughs
di: Alison Felipe Bordini Biggi, et al.
Pubblicazione: (2026)

Highlights of 2025: advancements in natural killer cell biology
di: Beatriz Aires‐Lopes, et al.
Pubblicazione: (2026)

Highlights of 2024. Broadening anti‐cancer immunotherapy modalities with antibody–drug conjugates: emerging insights from clinical studies
di: Jiya Jose, et al.
Pubblicazione: (2025)

Highlights of 2024: γδ T cells and bad blood
di: Matthias Eberl
Pubblicazione: (2025)

Highlights of 2024: New insights into the molecular regulation of antibody‐secreting cells and their subsets
di: Michael James Flaman, et al.
Pubblicazione: (2025)

Highlights of 2024: The rising role of age‐associated B cells in autoimmune diseases
di: Adrian YS Lee, et al.
Pubblicazione: (2025)

Highlights of 2025: plasma cell biology
di: Alexandra Bosak Karaviotis, et al.
Pubblicazione: (2026)

Highlight of 2023: Advances in mast cells
di: Jasmine Barra, et al.
Pubblicazione: (2024)

ICB Special Feature: Highlights of 2024
di: Joanne H Reed
Pubblicazione: (2025)

Highlights of 2024: Advances in Germinal Centers
di: Theresa E Pankhurst, et al.
Pubblicazione: (2025)

Highlight of 2023: big impacts of microRNAs in T cells
di: Yangnan Zhang, et al.
Pubblicazione: (2024)

Highlight of 2023: Virtues and vices of CD4 CAR T cells
di: Shivali Savita Chinni, et al.
Pubblicazione: (2024)

Highlight of 2023: Unconventional T cells: recent insights on development, trafficking and target cell recognition
di: Sarah Pasquin
Pubblicazione: (2024)

Highlights of 2024: Tregs immunometabolism and how to counter inflammatory niches
di: Nicolas Valentini, et al.
Pubblicazione: (2025)

Variations in the germinal center response revealed by genetically diverse mouse strains
di: Anne‐Marie Aubin, et al.
Pubblicazione: (2024)

ICBSpecial Feature: Highlights of 2023
di: Joanne H Reed
Pubblicazione: (2024)

Highlight of 2023: Microglia biology
di: Amy Dashwood, et al.
Pubblicazione: (2024)

Highlight of 2023: Tregs in the lungs
di: Ntombizodwa Makuyana, et al.
Pubblicazione: (2024)

CD49a expression defines a metabolically robust, cytokine‐biased liver NK cell subset in rhesus macaques during lentivirus infection
di: Andrew Hudson, et al.
Pubblicazione: (2026)

Highlights of 2025: advances in germinal centers
di: Louise MC Webb, et al.
Pubblicazione: (2026)

Highlight of 2023: Advances in germinal centers
di: Theresa E Pankhurst, et al.
Pubblicazione: (2024)

Highlight of 2023: Advances in pediatric immunology
di: Erika Van Nieuwenhove
Pubblicazione: (2024)

The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy
di: Timothy R McCulloch, et al.
Pubblicazione: (2024)

Cytokine armored CAR T cells for cancer immunotherapy
di: Kevin Sek, et al.
Pubblicazione: (2026)

Highlights of 2025: epithelial‐immune circuitry in allergic airway inflammation
di: Rebecca Palmer, et al.
Pubblicazione: (2026)

Serum proteomic and metabolomic analyses from patients with IBD identify biological pathways associated with treatment success with anti‐integrin therapy
di: John D Rioux, et al.
Pubblicazione: (2025)

Th17 cells in cancer: plasticity‐driven immunopathology and therapeutic opportunity
di: Henry Sutanto, et al.
Pubblicazione: (2025)

Characterization of ex vivo expanded natural killer cells for cancer immunotherapy
di: Jin Young Min, et al.
Pubblicazione: (2025)

ALDOB suppresses the activity of CD8+ T cells in colorectal cancer via the WNT signaling pathway
di: Jinwei Liu, et al.
Pubblicazione: (2025)

Therapy‐induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression
di: Anas HA Abu‐Humaidan, et al.
Pubblicazione: (2024)

Platforms for studying cell–cell recognition by immune cells
di: Jordan Kramer, et al.
Pubblicazione: (2025)

The power of networking in science and academia
di: Jessica G Borger
Pubblicazione: (2024)

Mapping T‐cell activation one cell at a time
di: Jessica G Borger, et al.
Pubblicazione: (2026)

The up‐regulation of PD‐L1 during boningmycin‐induced senescence in human cancer cells depends on the activation of the JAK/STAT signaling pathway mediated by SASP
di: Yang Chen, et al.
Pubblicazione: (2024)

Sketching T cell atlases in the single‐cell era: challenges and recommendations
di: Itana Bojović, et al.
Pubblicazione: (2025)

Identification of clonally expanded γδ T‐cell populations during CAR‐T cell therapy
di: Arman Safavi, et al.
Pubblicazione: (2024)

A new method to measure cell metabolism of rare cells in vivo reveals a high oxidative phosphorylation dependence of lung T cells
di: Aristeidis Roubanis, et al.
Pubblicazione: (2025)